DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Vinflunine is an investigational drug.
There have been 34 clinical trials for Vinflunine. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2009.
The most common disease conditions in clinical trials are Carcinoma, Carcinoma, Transitional Cell, and Urinary Bladder Neoplasms. The leading clinical trial sponsors are Bristol-Myers Squibb, Pierre Fabre Medicament, and National Cancer Institute (NCI).
Recent Clinical Trials for Vinflunine
|Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial Cancer||Immunomedics, Inc.||Phase 3|
|Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)||Apices Soluciones S.L.||Phase 1/Phase 2|
|Niraparib in Combination With Cabozantinib (XL184) in Patients With Advanced Urothelial Cancer (NICARAGUA)||Ipsen||Phase 1/Phase 2|